Stimulating angiotensin AT2 receptor lessens neuromyelitis optica spectrum disorder-like pathology

Takeaway

  • Stimulating the angiotensin AT2 receptor (AT2R) may be a potential therapeutic target for the treatment of neuromyelitis optica spectrum disorder (NMOSD).

Why this matters

    Current therapies for NMOSD have a limited effect on the frequency and severity of attacks. The results of this study suggest a potential therapeutic target for the treatment of NMOSD.